[Sinovac and Butantan Join Efforts to Advance the Clinical Development of An Inactivated Vaccine for COVID-19 to Phase III Beijing (China), Sao Paulo, (Brazil), June 11th, 2020 Science Sinovac has made significant progress in the development of CoronaVac. Promising preclinical results regarding Coron]
[Sinovac and Butantan Join Efforts to Advance the Clinical Development of An Inactivated Vaccine for COVID-19 to Phase III Beijing (China), Sao Paulo, (Brazil), June 11th, 2020 Science Sinovac has made significant progress in the development of CoronaVac. Promising preclinical results regarding Coron]
[Sinovac Secures $15 Million in Funding to Accelerate COVID-19 Vaccine Development BEIJING, May 22, 2020 -- (BUSINESS WIRE) -- Sinovac Biotech Ltd. (“Sinovac” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced a transaction in which Advantech C]
[Sinovac Secures $15 Million in Funding to Accelerate COVID-19 Vaccine Development BEIJING, May 22, 2020 -- (BUSINESS WIRE) -- Sinovac Biotech Ltd. (“Sinovac” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced a transaction in which Advantech C]
[Sinovac Comments on SEC Findings Against Jiaqiang "Chiang" Li and 1Globe Capital SEC Order found Li and 1Globe Violated SEC Rules and Federal Securities Laws by Failing to Disclose Key Facts regarding their Holdings of Sinovac The SEC also found that the participants in the activist plan were advise]
[Sinovac Comments on SEC Findings Against Jiaqiang "Chiang" Li and 1Globe Capital SEC Order found Li and 1Globe Violated SEC Rules and Federal Securities Laws by Failing to Disclose Key Facts regarding their Holdings of Sinovac The SEC also found that the participants in the activist plan were advise]
[] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to m]
[] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to m]
[Sinovac Announces First Animal Study Results of Vaccine Against COVID-19 Published in SCIENCE --- Inactivated vaccine for SARS-CoV-2 shows good safety and efficacy on Rhesus Macaques BEIJING, China, May 6, 2020 /Business Wire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a lea]
[Sinovac Announces First Animal Study Results of Vaccine Against COVID-19 Published in SCIENCE --- Inactivated vaccine for SARS-CoV-2 shows good safety and efficacy on Rhesus Macaques BEIJING, China, May 6, 2020 /Business Wire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a lea]
